Skip to main content

NATIXIS ADVISORS, LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1018331 Boston, MA

Position in CRNX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$815,568
+$145,174 QoQ
Shares Held
21,795
+18.1% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#132
of 264 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NATIXIS ADVISORS, LLC holds $495,549,179 across 38 Biotechnology names. CRNX ranks #30 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRNX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $815,568 21,795
2026-03-31 $670,394 18,458
2025-12-31 $932,629 20,035
2025-09-30 $2,155,220 51,746
2025-06-30 $1,355,027 47,115
2025-03-31 $1,559,911 46,509
2024-12-31 $2,335,771 45,683
2024-09-30 $2,266,080 44,346
2024-06-30 $1,454,600 32,476
2024-03-31 $1,283,717 27,424
2023-12-31 $908,748 25,541
2023-09-30 $762,236 25,630
2023-06-30 $367,373 20,387
2023-03-31 $324,765 20,222
2022-12-31 $215,281 11,764
2022-09-30 $232,694 11,848
2022-06-30 $221,506 11,877